Summary
The effect of intravesical administration of high dose recombinant tumor necrosis factor-α (rTNF) and in combination with systemic recombinant γ-interferon (rIFN) on murine bladder cancer was studied. RTNF was given at 12.5 μg/mouse on days 7, 11 and 15 after tumor instillation or at 2.5 μg/mouse on days 7, 9, 11, 13 and 15. Some groups were also injected i.v., 24-h prior to each rTNF treatment with rIFN at a dose of 1.3 μg/mouse. RTNF treatment suppressed tumor growth up to 48% of control, although the difference was not statistically significant. Combined administration of rIFN did not provide additional benefit.
Similar content being viewed by others
References
Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res 46:3990
Fransen L, Vander Heyden J, Ruysschaert R, Fiers W (1986) Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines. Eur J Cancer Clin Oncol 22:419
Jain RK (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res 47:3039
Lee K, Ewing JF, Sluss PM (1989) Effect of bacterial lipopolysaccaride on growth of murine bladder cancer, MBT-2. Urol Res 17:285
Lee K, O'Donnell RW, Schoen S, Cockett ATKC (1987) Effect of intravesical administration of tumor necrosis serum and human recombinant tumr necrosis factor on a murine bladder tumor. J Urol 138:430
O'Donnell RW, Laluppa JC, Lee K (1988) In vitro effect of tumor necrosis factor-alpha, interferon-gamma and macrophages on murine bladder tumor (MBT-2) cells. Proc Am Assoc Cancer Res 29:368 (Abstract 1464)
Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724
Schiller JH, Bitlner G, Storer B, Willson JK (1987) Synergistic antitumor effects of tumor necrosis factor and γ-interferon on colon carcinoma cell lines. Cancer Res 47:2809
Soloway MS (1977) Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 17:2918
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, K., O'Donnell, R.W. & Cockett, A.T.K. Influence of intravesical administration of tumor necrosis factor α and systemic γ-interferon on murine bladder cancer: Lack of dose response. Urol. Res. 18, 287–289 (1990). https://doi.org/10.1007/BF00294775
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00294775